Philippe Beuzeboc Selected Research

Philippe Beuzeboc Research Topics

Disease

45	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2002
32	Neoplasms (Cancer) 04/2024 - 04/2002
14	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2002
13	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
9	Carcinoma (Carcinomatosis) 11/2023 - 11/2003
6	Disease Progression 09/2020 - 05/2009
5	Pain (Aches) 03/2022 - 05/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2004
4	Neutropenia 01/2020 - 02/2013
3	Lung Neoplasms (Lung Cancer) 07/2015 - 01/2009
2	Fatigue 03/2022 - 01/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2012
2	Hypertension (High Blood Pressure) 01/2022 - 11/2015
2	Febrile Neutropenia 05/2019 - 02/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2015 - 01/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015 - 01/2002
2	Seminoma 02/2014 - 02/2003
2	Cardiotoxicity 06/2011 - 03/2007
2	Transitional Cell Carcinoma 07/2009 - 11/2005
1	COVID-19 01/2023
1	Alopecia (Baldness) 03/2022
1	Edema (Dropsy) 03/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Liver Failure 01/2022
1	Digestive System Diseases 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Heart Failure 01/2022
1	Massive Hepatic Necrosis 01/2022

Drug/Important Bio-Agent (IBA)

22	Docetaxel (Taxotere)FDA Link 10/2023 - 05/2005
19	AndrogensIBA 10/2023 - 11/2003
12	Hormones (Hormone)IBA 05/2019 - 11/2003
7	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 10/2005
7	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 05/2009
6	PlatinumIBA 04/2024 - 07/2009
6	Estramustine FDA Link 10/2023 - 05/2005
6	cabazitaxel FDA Link 03/2022 - 04/2011
6	Trastuzumab (Herceptin)FDA Link 01/2017 - 05/2004
5	Gemcitabine FDA Link 11/2023 - 10/2005
5	AnthracyclinesIBA 01/2017 - 04/2002
5	CreatinineIBA 12/2010 - 10/2005
4	Abiraterone AcetateIBA 02/2023 - 07/2012
4	Taxoids (Taxanes)IBA 03/2022 - 12/2010
4	Monoclonal AntibodiesIBA 01/2021 - 05/2004
3	abirateroneIBA 01/2023 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2004
3	Prednisone (Sone)FDA LinkGeneric 12/2020 - 05/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 12/2014
3	SaltsIBA 01/2015 - 03/2012
3	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2011 - 05/2005
2	sacituzumab govitecanIBA 04/2024 - 01/2021
2	NivolumabIBA 11/2023 - 01/2022
2	VaccinesIBA 01/2023 - 01/2022
2	olaparibIBA 01/2023 - 12/2020
2	pembrolizumabIBA 10/2022 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2020
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2003
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2017
2	Denosumab FDA Link 01/2019 - 11/2012
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 05/2014
2	Bevacizumab (Avastin)FDA Link 01/2017 - 11/2015
2	enzalutamideIBA 08/2015 - 01/2014
2	Alkaline PhosphataseIBA 08/2015 - 02/2012
2	Zoledronic Acid (Zometa)FDA Link 05/2014 - 11/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2014 - 02/2013
2	Etoposide (VP 16)FDA LinkGeneric 02/2014 - 07/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 07/2004
2	ZD4054IBA 10/2010 - 05/2009
2	Pain-FreeIBA 10/2010 - 05/2009
2	Endothelin A ReceptorIBA 10/2010 - 05/2009
2	human ERBB2 proteinIBA 03/2007 - 05/2004
1	Immune Checkpoint InhibitorsIBA 04/2024
1	darolutamideIBA 10/2023
1	Lipase (Acid Lipase)FDA Link 01/2022
1	BNT162 VaccineIBA 01/2022
1	IpilimumabIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	EnzymesIBA 12/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 04/2024 - 01/2002
30	Therapeutics 11/2023 - 01/2003
24	Castration 10/2023 - 05/2009
7	Radiotherapy 10/2021 - 01/2004
3	Adjuvant Chemotherapy 01/2017 - 07/2006
3	Cystectomy 01/2017 - 01/2004
2	Duration of Therapy 01/2020 - 04/2015
2	Chemoradiotherapy 06/2015 - 01/2004
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2012 - 09/2009
2	Lymph Node Excision (Lymph Node Dissection) 01/2012 - 02/2003
2	Drug Tapering 12/2010 - 10/2009
2	Aftercare (After-Treatment) 05/2009 - 04/2002
1	Immunotherapy 01/2022
1	Injections 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021